Borbath and colleagues reported that high expression of hENT1 was independently associated with prolonged PFS and OS in 26 patients with locally advanced or metastatic extrahepatic and intrahepatic cholangiocarcinoma who were treated with gemcitabine [19]. The gene discussed is SLC29A1; the disease is intrahepatic cholangiocarcinoma.